Publications by authors named "Marianna Manfrini"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

7,880

Total Likes

92

Extended Reach

41,972

Social Features

26
E
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Amit Bar-Or, Jonathan C Calkwood, Cathy Chognot, Joanna Evershed, Edward J Fox, Ann Herman, Marianna Manfrini, John McNamara, Derrick S Robertson, Daniela Stokmaier

Neurology· October 2020

Videos about Article: user user user

3 23 3 5

View All Article and Social Media Activity
Q
Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical Trial.
Krista Vandenborne, Glenn A Walter, Volker Straub, Rebecca J Willcocks, Sean C Forbes, Marianna Manfrini

JAMA Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
Hans-Peter Hartung, Thomas Berger, Robert A Bermel, Bruno Brochet, William M Carroll, Marianna Manfrini

J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating drug concentration-response relationships by applying causal inference methods for continuous point exposures and time-to-event outcomes.
Sean Yiu, Qing Wang, Francois Mercier, Marianna Manfrini, Harold Koendgen

Stat Methods Med Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Martin S Weber, Heidemarie Kletzl, Andreas Günther, Marianna Manfrini

Neurol Neuroimmunol Neuroinflamm· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent disability progression endpoints in multiple sclerosis clinical trials.
Alexandra Bühler, Marcel Wolbers, Fabian Model, Qing Wang, Shibeshih Belachew, Marianna Manfrini

Mult Scler· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials.
Gavin Giovannoni, Ludwig Kappos, Jerome de Seze, Stephen L Hauser, James Overell, Marianna Manfrini

Eur J Neurol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma.
Shiao-Pei Weathers, Julie Rood-Breithaupt, John de Groot, Gail Thomas, Marianna Manfrini

Neurooncol Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial.
Jerry S Wolinsky, Douglas L Arnold, Bruno Brochet, Hans-Peter Hartung, Xavier Montalban, Marianna Manfrini

Lancet Neurol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.
Ludwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, Douglas L Arnold, Qing Wang, Marianna Manfrini

JAMA Neurol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
Stephen L Hauser, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Bruno Brochet, Marianna Manfrini

Neurology· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis